Article and Video CATEGORIES
This pilot video slide presentation covers the development of our current standards for first line chemotherapy to treat advanced non-small cell lung cancer.
[powerpress]
These series will be called GRACEcasts (love it?), and we're in the process of developing a bunch of audio interviews with experts for an audio channel, and multiple video presentations, which are going to be about 10 minutes each, just little chapters at one time.
And you don't need to worry about getting all of the information in one viewing, because we'll plan to upload a copy of the slides and a transcript of the narration that you can download and review anytime.
Adv NSCLC First Line Chemo Slide Set
Adv NSCLC First Line Chemo Transcript
Where to next? Here's a list of some planned video GRACEcasts for the coming months:
Intro to SCLC
Limited SCLC
First Line Treatment of SCLC
Relapsed SCLC
General principles of Adjuvant Therapy for Resected NSCLC
Adjuvant Chemo for Stage I NSCLC
Management Options for Stage IIIA NSCLC
Optimal Treatment of Unresectable Locally Adv NSCLC
Angiogenesis for First Line Treatment of Adv NSCLC
EGFR-Based Therapy for Advanced NSCLC
Second Line Chemo for Adv NSCLC
Timing Therapy in Adv NSCLC: The Evolving Role of Maintenance Therapy
Rash/toxicity Management with EGFR Inhibitors
Histology Matters: Tailoring therapy by Histology for NSCLC
Molecular markers for EGFR-based Therapy
Treatment of Poor risk/elderly pts with Adv NSCLC
Combinations of Targeted Therapies
Multi-Targeted Therapies
Got ideas for more topics? We're open to suggestions. And we'd also be eternally grateful for sponsorhip of one of these key presentations, a great way to show your support for the cancer community. Just e-mail us at info@cancergrace.org.
We hope you like our transition into audio and video.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…